Comparative requirements for the restriction of retrovirus infection by TRIM5α and TRIMCyp

Anderson, 2006, Proteasome inhibition reveals that a functional preintegration complex intermediate can be generated during restriction by diverse TRIM5 proteins, J. Virol., 80, 9754, 10.1128/JVI.01052-06 Cowan, 2002, Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism, Proc. Natl. Acad. Sci. U. S. A., 99, 11914, 10.1073/pnas.162299499 Diaz-Griffero, 2006, Rapid turnover and polyubiquitylation of the retroviral restriction factor TRIM5, Virology, 349, 300, 10.1016/j.virol.2005.12.040 Diaz-Griffero, 2006, Requirements for capsid-binding and an effector function in TRIMCyp-mediated restriction of HIV-1, Virology, 351, 404, 10.1016/j.virol.2006.03.023 Diaz-Griffero, 2007, Modulation of retroviral restriction and proteasome inhibitor-resistant turnover by changes in the TRIM5{alpha} B-box 2 domain, J. Virol., 81, 10362, 10.1128/JVI.00703-07 Gamble, 1996, Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid, Cell, 87, 1285, 10.1016/S0092-8674(00)81823-1 Ganser, 1999, Assembly and analysis of conical models for the HIV-1 core, Science, 283, 80, 10.1126/science.283.5398.80 Ganser-Pornillos, 2004, Assembly properties of the human immunodeficiency virus type 1 CA protein, J. Virol., 78, 2545, 10.1128/JVI.78.5.2545-2552.2004 Hatziioannou, 2004, Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha, Proc. Natl. Acad. Sci. U. S. A., 101, 10774, 10.1073/pnas.0402361101 Hatziioannou, 2005, Cyclophilin interactions with incoming human immunodeficiency virus type 1 capsids with opposing effects on infectivity in human cells, J. Virol., 79, 176, 10.1128/JVI.79.1.176-183.2005 Hofmann, 1999, Species-specific, postentry barriers to primate immunodeficiency virus infection, J. Virol., 73, 10020, 10.1128/JVI.73.12.10020-10028.1999 Javanbakht, 2005, The contribution of RING and B-box 2 domain in retroviral restriction mediated by monkey TRIM5alpha, J. Biol. Chem., 29, 26933, 10.1074/jbc.M502145200 Javanbakht, 2006, Characterization of TRIM5alpha trimerization and its contribution to human immunodeficiency virus capsid binding, Virology, 353, 234, 10.1016/j.virol.2006.05.017 Javanbakht, 2007, The ability of multimerized cyclophilin A to restrict retrovirus infection, Virology, 10.1016/j.virol.2007.04.034 Keckesova, 2004, The human and African green monkey TRIM5alpha genes encode Ref1 and Lv1 retroviral restriction factor activities, Proc. Natl. Acad. Sci. U. S. A., 101, 10780, 10.1073/pnas.0402474101 Li, 2006, Removal of arginine 332 allows human TRIM5alpha to bind human immunodeficiency virus capsids and to restrict infection, J. Virol., 80, 6738, 10.1128/JVI.00270-06 Lin, 2006, Cyclophilin A interacts with diverse lentiviral capsids, Retrovirology, 3, 70, 10.1186/1742-4690-3-70 Luban, 1993, Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B, Cell, 73, 1067, 10.1016/0092-8674(93)90637-6 Mische, 2005, Retroviral restriction factor TRIM5alpha is a trimer, J. Virol., 79, 14446, 10.1128/JVI.79.22.14446-14450.2005 Munk, 2002, A dominant block to HIV-1 replication at reverse transcription in simian cells, Proc. Natl. Acad. Sci. U. S. A., 99, 13843, 10.1073/pnas.212400099 Nisole, 2004, A TRIM5–cyclophilin A fusion protein found in owl monkey kidney cells can restrict HIV-1, Proc. Natl. Acad. Sci. U. S. A., 101, 13324, 10.1073/pnas.0404640101 Olsen, 1998, Gene transfer vectors derived from equine infectious anemia virus, Gene Ther., 5, 1481, 10.1038/sj.gt.3300768 Owens, 2003, Human and simian immunodeficiency virus capsid proteins are major viral determinants of early, postentry replication blocks in simian cells, J. Virol., 77, 726, 10.1128/JVI.77.1.726-731.2003 Owens, 2004, Binding and susceptibility to postentry restriction factors in monkey cells are specified by distinct regions of the human immunodeficiency virus type 1 capsid, J. Virol., 78, 5423, 10.1128/JVI.78.10.5423-5437.2004 Perez-Caballero, 2005, Human tripartite motif 5alpha domains responsible for retrovirus restriction activity and specificity, J. Virol., 79, 8969, 10.1128/JVI.79.14.8969-8978.2005 Perez-Caballero, 2005, Restriction of human immunodeficiency virus type 1 by TRIM—CypA occurs with rapid kinetics and independently of cytoplasmic bodies, ubiquitin, and proteasome activity, J. Virol., 79, 15567, 10.1128/JVI.79.24.15567-15572.2005 Perron, 2006, Two surface-exposed elements of the B30.2/SPRY domain as potency determinants of N-tropic murine leukemia virus restriction by human TRIM5alpha, J. Virol., 80, 5631, 10.1128/JVI.00219-06 Perron, 2007, The human TRIM5alpha restriction factor mediates accelerated uncoating of the N-tropic murine leukemia virus capsid, J. Virol., 81, 2138, 10.1128/JVI.02318-06 Ribeiro, 2005, Evolution of cyclophilin A and TRIMCyp retro-transposition in New World primates, J. Virol., 79, 14998, 10.1128/JVI.79.23.14998-15003.2005 Saenz, 2005, Restriction of feline immunodeficiency virus by Ref1, Lv1, and primate TRIM5alpha proteins, J. Virol., 79, 15175, 10.1128/JVI.79.24.15175-15188.2005 Sawyer, 2005, Positive selection of primate TRIM5alpha identifies a critical species-specific retroviral restriction domain, Proc. Natl. Acad. Sci. U. S. A., 102, 2832, 10.1073/pnas.0409853102 Sayah, 2004, Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1, Nature, 430, 569, 10.1038/nature02777 Song, 2005, The B30.2(SPRY) domain of the retroviral restriction factor TRIM5alpha exhibits lineage-specific length and sequence variation in primates, J. Virol., 79, 6111, 10.1128/JVI.79.10.6111-6121.2005 Song, 2005, Retrovirus restriction by TRIM5alpha variants from Old World and New World primates, J. Virol., 79, 3930, 10.1128/JVI.79.7.3930-3937.2005 Stremlau, 2004, The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys, Nature, 427, 848, 10.1038/nature02343 Stremlau, 2005, Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction, J. Virol., 79, 3139, 10.1128/JVI.79.5.3139-3145.2005 Stremlau, 2006, Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor, Proc. Natl. Acad. Sci. U. S. A., 103, 5514, 10.1073/pnas.0509996103 Towers, 2003, Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors, Nat. Med., 9, 1138, 10.1038/nm910 Wu, 2006, Proteasome inhibitors uncouple rhesus TRIM5alpha restriction of HIV-1 reverse transcription and infection, Proc. Natl. Acad. Sci. U. S. A., 103, 7465, 10.1073/pnas.0510483103 Yap, 2005, A single amino acid change in the SPRY domain of human TRIM5alpha leads to HIV-1 restriction, Curr. Biol., 15, 73, 10.1016/j.cub.2004.12.042 Yap, 2007, The design of artificial retroviral restriction factors, Virology, 365, 302, 10.1016/j.virol.2007.04.005 Yin, 1998, Human immunodeficiency virus type 1 replication is modulated by host cyclophilin A expression levels, J. Virol., 72, 6430, 10.1128/JVI.72.8.6430-6436.1998